An oncogenic role for alternative NF-κB signaling in DLBCL revealed upon deregulated BCL6 expression.
An oncogenic role for alternative NF-κB signaling in DLBCL revealed upon deregulated BCL6 expression.
复制标题
DOI:
10.1016/j.celrep.2015.03.059
复制
发表时间:
2015-05-05
期刊:
影响因子:
8.8
通讯作者:
Rajewsky K
中科院分区:
文献类型:
--
作者:
Zhang B;Calado DP;Wang Z;Fröhler S;Köchert K;Qian Y;Koralov SB;Schmidt-Supprian M;Sasaki Y;Unitt C;Rodig S;Chen W;Dalla-Favera R;Alt FW;Pasqualucci L;Rajewsky K
Diffuse large B cell lymphoma (DLBCL) is a complex disease comprising diverse subtypes and genetic profiles. Possibly due to the prevalence of genetic alterations activating canonical NF-κB activity, a role for oncogenic lesions that activate the alternative NF-κB pathway in DLBCL has remained elusive. Here we show that deletion/mutation of TRAF3, a negative regulator of the alternative NF-κB pathway, occurs in ∼15% of DLBCLs, and that it often coexists with BCL6 translocation, which prevents terminal B cell differentiation. Accordingly, in a mouse model constitutive activation of the alternative NF-κB pathway cooperates with BCL6 deregulation in DLBCL development. This work demonstrates a key oncogenic role for the alternative NF-κB pathway in DLBCL development.
登录
查看更多内容
影响因子:
50.3
作者:
Calado DP;Zhang B;Srinivasan L;Sasaki Y;Seagal J;Unitt C;Rodig S;Kutok J;Tarakhovsky A;Schmidt-Supprian M;Rajewsky K
通讯作者:
Rajewsky K
影响因子:
15.3
作者:
Grumont, R J;Gerondakis, S
通讯作者:
Gerondakis, S
影响因子:
50.3
作者:
Mandelbaum J;Bhagat G;Tang H;Mo T;Brahmachary M;Shen Q;Chadburn A;Rajewsky K;Tarakhovsky A;Pasqualucci L;Dalla-Favera R
通讯作者:
Dalla-Favera R
影响因子:
5.3
作者:
O'Mahony, A;Lin, X;Greene, WC
通讯作者:
Greene, WC
影响因子:
56.9
作者:
Lenz, Georg;Davis, R. Eric;Staudt, Louis M.
通讯作者:
Staudt, Louis M.